Skip to main content

Subcutaneous apomorphine in Parkinson’s disease

  • Conference paper

Part of the book series: Key Topics in Brain Research ((KEYTOPICS))

Summary

Motor function in patients who are disabled by parkinsonian on-off oscillations can be significantly improved by administration of subcutaneous apomorphine by diurnal infusion or intermittent injection. In conjunction with use of the peripherally acting dopamine receptor antagonist domperidone, this treatment is well tolerated and has produced prolonged benefit in patients suffering from the most intractable complication of prolonged L-dopa therapy.

This is a preview of subscription content, log in via an institution.

Buying options

Chapter
USD   29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD   39.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD   54.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Learn about institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  • Corsini GU, Del Zompo M, Gessa GL, Mangoni A (1979) Therapeutic efficacy of apomorphine combined with an extracerebral inhibitor of dopamine receptors in Parkinson’s disease. Lancet i: 954–956

    Google Scholar 

  • Cotzias GC, Papavassilou PS, Fehling C, Kaufman B, Mena I (1970) Similarities between neurological effects of L-dopa and apomorphine. N Engl J Med 282: 31–33

    Article  PubMed  CAS  Google Scholar 

  • Critchley P, Perez F, Quinn N, Coleman R, Parkes D, Marsden CD (1986). Psychosis and the lisuride pump. Lancet ii: 349

    Google Scholar 

  • Kempster PA, Lees AJ, Crichton P, Frankel JP, Shorvon P (1988) Off period belching due to a reversible disturbance of oesophageal motility in Parkinson’s disease and its treatment with apomorphine. Movement Disorders (in press)

    Google Scholar 

  • Quinn N, Parkes JD, Marsden CD (1984). Control of the on/off phenomenon by intravenous infusion of L-dopa. Neurology 34: 1131–1136

    PubMed  CAS  Google Scholar 

  • Stibe CMH, Lees AJ, Stern GM (1987) Subcutaneous infusion of apomorphine and lisuride in the treatment of parkinsonian on-off oscillations. Lancet is 871

    Google Scholar 

  • Stibe CMH, Lees AJ, Kempster PA, Stern GM (1988) Subcutaneous apo- morphine in parkinsonian on-off oscillations. Lancet ii 403–406

    Article  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 1989 Springer-Verlag/Wien

About this paper

Cite this paper

Stibe, C.M.H., Kempster, P.A., Lees, A.J., Stern, G.M. (1989). Subcutaneous apomorphine in Parkinson’s disease. In: Przuntek, H., Riederer, P. (eds) Early Diagnosis and Preventive Therapy in Parkinson’s Disease. Key Topics in Brain Research. Springer, Vienna. https://doi.org/10.1007/978-3-7091-8994-8_41

Download citation

  • DOI: https://doi.org/10.1007/978-3-7091-8994-8_41

  • Publisher Name: Springer, Vienna

  • Print ISBN: 978-3-211-82080-3

  • Online ISBN: 978-3-7091-8994-8

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics